MRVI (STOCKS)
Maravai LifeSciences Holdings, Inc. Class A Common Stock
$5.780000
+0.000000 (+0.00%)
Prev close: $5.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bernd Brust
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,342.41M
- Employees
- 560
- P/E (TTM)
- -10.86
- P/B (TTM)
- 4.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.02 | $-0.04 | +0.0241 | +54.65% |
|
Mar 2026 (Q1)
|
$0.01 | $-0.05 | +0.0581 | +120.79% |
|
Dec 2025 (Q4)
|
$-0.04 | $-0.07 | +0.0323 | +44.68% |
|
Sep 2025 (Q3)
|
$-0.08 | $-0.08 | +0.0033 | +3.96% |
Financial Statements
| Revenues | $208.78M |
| Benefits Costs and Expenses | $345.26M |
| Cost Of Revenue | $135.93M |
| Costs And Expenses | $189.92M |
| Gross Profit | $72.85M |
| Operating Expenses | $189.92M |
| Selling, General, and Administrative Expenses | $128.14M |
| Research and Development | $15.22M |
| Other Operating Expenses | $46.56M |
| Operating Income/Loss | -$117.07M |
| Income/Loss From Continuing Operations After Tax | -$136.08M |
| Income/Loss From Continuing Operations Before Tax | -$136.49M |
| Income Tax Expense/Benefit | -$408.00K |
| Net Income/Loss | -$136.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$58.69M |
| Net Income/Loss Attributable To Parent | -$77.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.52 |
| Diluted Earnings Per Share | -$0.52 |
| Basic Average Shares | 439,346,000 |
| Diluted Average Shares | 439,346,000 |
| Assets | $603.75M |
| Current Assets | $155.66M |
| Inventory | $41.23M |
| Other Current Assets | $114.43M |
| Noncurrent Assets | $448.09M |
| Intangible Assets | $138.38M |
| Other Non-current Assets | $309.72M |
| Liabilities | $248.16M |
| Current Liabilities | $38.42M |
| Accounts Payable | $7.13M |
| Other Current Liabilities | $31.29M |
| Noncurrent Liabilities | $209.74M |
| Long-term Debt | $147.11M |
| Other Non-current Liabilities | $62.63M |
| Equity | $355.59M |
| Equity Attributable To Noncontrolling Interest | $150.97M |
| Equity Attributable To Parent | $204.62M |
| Liabilities And Equity | $603.75M |
| Net Cash Flow From Operating Activities | -$25.26M |
| Net Cash Flow From Operating Activities, Continuing | -$25.26M |
| Net Cash Flow From Investing Activities | -$9.85M |
| Net Cash Flow From Investing Activities, Continuing | -$9.85M |
| Net Cash Flow From Financing Activities | -$164.27M |
| Net Cash Flow From Financing Activities, Continuing | -$164.27M |
| Exchange Gains/Losses | $53.00K |
| Net Cash Flow | -$199.33M |
| Net Cash Flow, Continuing | -$199.38M |
| Comprehensive Income/Loss | -$136.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$58.79M |
| Comprehensive Income/Loss Attributable To Parent | -$77.50M |
| Other Comprehensive Income/Loss | -$206.00K |